Literature DB >> 25485494

Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses.

Xiangyu Zhou1, Lluis Cordon-Barris, Tinatin Zurashvili, Jose Ramon Bayascas.   

Abstract

The PI3K/PDK1/PKB signaling pathway plays essential roles in regulating neuronal survival, differentiation and plasticity in response to neurotrophic factors, neurotransmitters and ion channels. Both PDK1 and PKB can interact at the plasma membrane with a phosphoinositide synthesized by PI3K, the second messenger PtdIns(3,4,5)P3, enabling PDK1 to phosphorylate and activate PKB. In the PDK1 K465E knock-in mice expressing a mutant form of PDK1 incapable of phosphoinositide binding, activation of PKB was markedly affected, but not totally abolished. It has been recently proposed that in the absence of PtdIns(3,4,5)P3 binding, PDK1 can still moderately activate PKB due to a docking site-mediated interaction of these 2 kinases. A recent report has uncovered that in the PDK1 K465E mice neurons, a PKB signal threshold was sufficient to support neuronal survival responses, whereas neuritogenesis, neuronal polarization and axon outgrowth were severely impaired. We propose here that the low-efficiency mechanism of PKB activation observed in the PDK1 K465E mice might represent the ancestral mechanism responsible for the essential functions of this pathway, while the phosphoinositide-dependent activation should be considered an evolutionary innovation that enabled the acquisition of novel functions.

Entities:  

Keywords:  PDK1; PH-domain; PKB/Akt; knock-in mice; neuronal morphogenesis; neuronal survival; phosphoinositides

Mesh:

Substances:

Year:  2014        PMID: 25485494      PMCID: PMC4614834          DOI: 10.4161/15384101.2014.962954

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

1.  Cloning and characterisation of PKB and PRK homologs from Hydra and the evolution of the protein kinase family.

Authors:  Michaela Herold; Mihai Cikala; Harry MacWilliams; Charles N David; Angelika Böttger
Journal:  Dev Genes Evol       Date:  2002-09-18       Impact factor: 0.900

2.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon.

Authors:  D Parekh; W Ziegler; K Yonezawa; K Hara; P J Parker
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.

Authors:  Ricardo M Biondi; David Komander; Christine C Thomas; Jose M Lizcano; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

5.  High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate.

Authors:  Christine C Thomas; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  Curr Biol       Date:  2002-07-23       Impact factor: 10.834

6.  In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.

Authors:  Barry J Collins; Maria Deak; J Simon C Arthur; Laura J Armit; Dario R Alessi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

7.  Phosphoinositide-dependent kinase-1 orthologues from five eukaryotes are activated by the hydrophobic motif in AGC kinases.

Authors:  Joachim Silber; Torben L Antal; Steen Gammeltoft; Thomas E Rasmussen
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

8.  Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change.

Authors:  Christine C Milburn; Maria Deak; Sharon M Kelly; Nick C Price; Dario R Alessi; Daan M F Van Aalten
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 9.  PDK1, the master regulator of AGC kinase signal transduction.

Authors:  Alfonso Mora; David Komander; Daan M F van Aalten; Dario R Alessi
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

10.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

View more
  12 in total

1.  Mutation of the 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Substrate-Docking Site in the Developing Brain Causes Microcephaly with Abnormal Brain Morphogenesis Independently of Akt, Leading to Impaired Cognition and Disruptive Behaviors.

Authors:  Lluís Cordón-Barris; Sònia Pascual-Guiral; Shaobin Yang; Lydia Giménez-Llort; Silvia Lope-Piedrafita; Carlota Niemeyer; Enrique Claro; Jose M Lizcano; Jose R Bayascas
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

2.  Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder.

Authors:  Siroshini K Thiagarajan; Siew Ying Mok; Satoshi Ogawa; Ishwar S Parhar; Pek Yee Tang
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

3.  Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses.

Authors:  Deborah Balzano; Mohamad-Ali Fawal; Jose V Velázquez; Clara M Santiveri; Joshua Yang; Joaquín Pastor; Ramón Campos-Olivas; Nabil Djouder; Daniel Lietha
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

4.  Structural basis of Focal Adhesion Kinase activation on lipid membranes.

Authors:  Iván Acebrón; Ricardo D Righetto; Christina Schoenherr; Svenja de Buhr; Pilar Redondo; Jayne Culley; Carlos F Rodríguez; Csaba Daday; Nikhil Biyani; Oscar Llorca; Adam Byron; Mohamed Chami; Frauke Gräter; Jasminka Boskovic; Margaret C Frame; Henning Stahlberg; Daniel Lietha
Journal:  EMBO J       Date:  2020-08-11       Impact factor: 11.598

5.  Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.

Authors:  Alice Cani; Carolina Simioni; Alberto M Martelli; Giorgio Zauli; Giovanna Tabellini; Simona Ultimo; James A McCubrey; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2015-03-30

6.  The miR-23a~27a~24-2 microRNA cluster buffers transcription and signaling pathways during hematopoiesis.

Authors:  Jeffrey L Kurkewich; Justin Hansen; Nathan Klopfenstein; Helen Zhang; Christian Wood; Austin Boucher; Joseph Hickman; David E Muench; H Leighton Grimes; Richard Dahl
Journal:  PLoS Genet       Date:  2017-07-13       Impact factor: 5.917

7.  Presynaptic Aβ40 prevents synapse addition in the adult Drosophila neuromuscular junction.

Authors:  Begoña López-Arias; Enrique Turiégano; Ignacio Monedero; Inmaculada Canal; Laura Torroja
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

8.  Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides.

Authors:  Shaobin Yang; Sònia Pascual-Guiral; Rebeca Ponce; Lydia Giménez-Llort; María A Baltrons; Ottavio Arancio; Jose R Palacio; Victoria M Clos; Victor J Yuste; Jose R Bayascas
Journal:  Front Aging Neurosci       Date:  2018-01-08       Impact factor: 5.750

9.  The Impact of the PI3K/Akt Signaling Pathway in Anxiety and Working Memory in Young and Middle-Aged PDK1 K465E Knock-In Mice.

Authors:  Lydia Giménez-Llort; Mikel Santana-Santana; José Ramón Bayascas
Journal:  Front Behav Neurosci       Date:  2020-05-08       Impact factor: 3.558

10.  Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.

Authors:  Estefania Alcaraz; Jordi Vilardell; Christian Borgo; Eduard Sarró; Maria Plana; Oriano Marin; Lorenzo A Pinna; José R Bayascas; Anna Meseguer; Mauro Salvi; Emilio Itarte; Maria Ruzzene
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.